#1Q4 and Full Year 2022 Results Nasdaq Global Market: CCLD, CCLDP, CCLDO A leading healthcare technology company with a complete suite of proprietary, cloud-based solutions for healthcare providers CareCloud, Inc. 2023 CareCloud#2Safe Harbor Statements This presentation contains forward-looking statements within the meaning of the federal securities laws. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "shall," "should," "could," "intends," "expects," "plans," "goals," "projects," "anticipates," "believes," "seeks," "estimates," "forecasts," "predicts," "possible," "potential," "target," or "continue" or the negative of these terms or other similar terms and phrases. Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this presentation include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, including our ability to continue as a going concern, to raise additional capital and to succeed in our future operations, profitability and business outlook, increased sales and marketing expenses, and the expected results from the integration of our acquisitions. Forward-looking statements are only current predictions and are subject to substantial known and unknown risks, uncertainties, and other factors that may cause our (or our industry's) actual results, levels of activity, performance, or achievements to be materially different from those anticipated by such statements. These factors include our ability to: Manage our growth, including acquiring, partnering with, and effectively integrating acquired businesses into our infrastructure and avoiding legal exposure and liabilities associated with acquired companies and assets; Retain our clients and revenue levels, including effectively migrating new clients and maintaining or growing the revenue levels of our new and existing clients; Maintain operations in our offshore offices in a manner that continues to enable us to offer competitively priced products and services; Keep pace with a rapidly changing healthcare industry; Consistently achieve and maintain compliance with a myriad of federal, state, foreign, local, payor and industry requirements, regulations, rules, laws and contracts; Maintain and protect the privacy of confidential and protected Company, client and patient information; Develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards and third-party software platforms and technologies, and protect and enforce all of these and other intellectual property rights; Attract and retain key officers and employees, and the continued involvement of Mahmud Haq as Executive Chairman and A. Hadi Chaudhry as Chief Executive Officer and President, all of which are critical to our ongoing operations, growing our business and integrating of our newly acquired businesses; Comply with covenants contained in our credit agreement with our senior secured lender, Silicon Valley Bank and other future debt facilities; Pay our monthly preferred dividends to the holders of our preferred stock; Compete with other companies developing products and selling services competitive with ours, and who may have greater resources and name recognition than we have; Respond to the uncertainty resulting from the ongoing Covid-19 pandemic and the impact it may have on our operations, the demand for our services, our projected results of operations, financial performance or other financial metrics or any of the foregoing risks and economic activity in general; and Keep and increase market acceptance of our products and services. Although we believe that the expectations reflected in the forward-looking statements contained in this presentation are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. In this presentation, we disclose certain non-GAAP historical and projected financial measures, including adjusted EBITDA. We believe that these non-GAAP financial measures provide useful information to both management and investors by excluding certain items and expenses that are not indicative of our core operating results or do not reflect our normal business operations. Our use of non-GAAP financial measures has certain limitations in that such non-GAAP financial measures may not be directly comparable to those reported by other companies. We seek to compensate for the limitation of our non-GAAP presentation by providing a detailed reconciliation of the non-GAAP financial measures to the most directly comparable U.S. GAAP measures. Investors are encouraged to review the related U.S. GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable U.S. GAAP financial measures. The statements in this presentation are made as of the date of this presentation, and the Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made. CareCloud O CareCloud, Inc. 2023 1#3Hosts for Fourth Quarter Earnings Call CareCloud Mahmud Haq Executive Chairman A. Hadi Chaudhry CEO and President Bill Korn Chief Financial Officer Kimberly Blanche General Counsel O CareCloud, Inc. 2023 2#4CareCloud Hadi Chaudhry CEO and President CareCloud, Inc. 20 O#5CareCloud Wellness CareCloud ... HYPERTENSION DIABETES EHR MMM = +8||| HIGH CHOLESTEROL OBESITY 0 128 80 O CareCloud, Inc. 2023 4#6medSR Update Revenue $30 $24 $18 $12 $6 $0 CareCloud $ millions medSR Revenue & Contribution Margin $30 14% $27 3% FY 2021 Annualized FY 2022 Contribution Margin 15% 12% 9% 6% 3% 0% O CareCloud, Inc. 2023 LO 5#7Our Tech-Enabled Revenue Cycle Solution Redefining the next generation of technology-enabled revenue cycle solutions TECHNOLOGY- ENABLED RCM • Revenue Cycle Management • Medical Coding • Provider Credentialing • Robotic Process Automation CareCloud CLOUD-BASED SOFTWARE Electronic Health Records • Practice Management Software Patient Experience Management ◆ Business Intelligence • Customized Cloud Applications DIGITAL HEALTH • Chronic Care Management • Remote Patient Monitoring • Telemedicine Solutions HIT PROFESSIONAL SERVICES & STAFFING Professional Services & Consulting • Strategic Advisory Services • Workforce Augmentation MEDICAL PRACTICE MANAGEMENT • Medical Practice Management Services O CareCloud, Inc. 2023 6#8Recurring bookings $ millions $10 Organic Growth $8 $6 $4 $2 $0 0.44 x Recurring bookings and Customer acquistion cost CareCloud 0.66 x Ilı $6 $7 0.32 x Customer acquistion $8 cost GL Q1 2020 Q2 2020 Q3 2020 Q4 2020 Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022 Q2 2022 Q3 2022 Q4 2022 0.75 X 0.60 x 0.45 x 0.30 x 0.15 x 0.0 x 60 30 Sales & Marketing Employees O Jan 1, 2020 Dec 31, 2022 O CareCloud, Inc. 2023 7#9Physical Therapy EHR CareCloud 2 therapy EHR O CareCloud, Inc. 2023 8#10Emerging Opportunities CareCloud Kuwait Bahrain Saudi Arabia Qatar United Arab Emirates Oman Map from Gulf Cooperation Council - Gulf Cooperation Council - Wikipedia O CareCloud, Inc. 2023 9#11CareCloud Bill Korn Chief Financial Officer O CareCloud, Inc. 20 10#12Q4 2022 and FY 2022 Highlights Net income +92% $32.5 Revenue (1%) $139.6 $138.8 Q4 2022 FY 2021 FY 2022 CareCloud $0.5 $2.8 $5.4 Q4 2022 FY 2021 FY 2022 Adjusted EBITDA $5.7 +1% $22.1 $22.2 Q4 2022 FY 2021 FY 2022 $ in millions. Percent change reflects FY 2021 to FY 2022 See reconciliations of non-GAAP results in the Appendix Adjusted net income (12%) $18.5 $16.3 $3.9 11 Q4 2022 FY 2021 FY 2022 O CareCloud, Inc. 2023 11#13FY 2022 Revenues ■ Technology- enabled business solutions ■ Medical practice management ■ Other healthcare IT services FY 2022 Revenues CareCloud $3.4 $13.6 $121.8 88% 52% 12% 24% FY 2022 Revenue Technology-enabled services 12% 10% 2% Other services ■ Technology-enabled revenue cycle management Cloud-based software- as-a-service Healthcare IT professional services ■ Medical practice management ■ Other services Most customers who utilize technology-enabled revenue cycle management use one or more elements of CareCloud's core technology (EHR or PM) O CareCloud, Inc. 2023 12#14Revenue 2021 2022 plus 2023 Guidance: 12% Net Organic Growth Total Revenue - CareCloud ($ in millions) Excluding 2 large customers each acquired prior to our taking over their contracts via one of our 2020 acquisitions $139.6 $118.1 2021 $138.8 $126.7 +7% 2022 $142 - $146 $140- $144 +12% 2023 Guidance Range ☐2 acquired customers Guidance Actual Percentages represent year-over-year growth excluding the two large customers acquired before one of our 2020 acquisitions, which migrated to their acquirers' platforms in mid-2022 Does not include the impact of any potential acquisitions Investors are cautioned that such statements involve risks and uncertainties CareCloud, Inc. 2023 that could cause actual results to differ materially from anticipated results 13#15Adjusted EBTIDA 2021 2022 plus 2023 Guidance: 15% Growth $24-$27 +15% CareCloud ($ in millions) - $22.1 2021 $22.2 2022 2023 Guidance ■ Range Guidance Actual Investors are cautioned that such statements involve risks and uncertainties that could cause actual results to differ materially from anticipated results See reconciliations of non-GAAP results in the Appendix O CareCloud, Inc. 2023 14#16Capitalization as of February 17, 2023 Stock Symbol Stock Price¹ Outstanding Shares¹ Equity Value Share Structure/ Terms Common Stock Nasdaq: CCLD $4.11 15.4 million $63 million CareCloud Public Float: 10 M shares Fully Diluted: 17.4 M shares Insiders: ~35% Series A Preferred Stock Nasdaq: CCLDP $27.59 4.5 million $125 million Dividend: 11% of redemption value ($25.00), paid monthly Non-convertible Redeemable at $25.00 per share at Company's option Redemption value: $113 M Series B Preferred Stock Nasdaq: CCLDO $25.05 1.4 million $35 million Dividend: 8.75% of redemption value ($25.00), paid monthly Non-convertible Redeemable at $25.75 per share starting 2/2024, steps down to $25.00 by 2/2027 Redemption value: $35 M ¹ Stock prices and shares as of February 17, 2023. Debt and cash as of December 31, 2022. $ Millions $250 $200 $150 $100 $50 CareCloud Enterprise Value $63 $160 $8.0 $12.3 $219 Common Preferred Stock Stock Debt Cash Enterprise Value O CareCloud, Inc. 2023 15#17CareCloud Thank You O CareCloud, Inc. 2023 16#18CareCloud Appendix Ⓒ CareCloud, Inc. 2023 17#19Non-GAAP Financial Measures Reconciliation Adjusted EBITDA to GAAP net income ($000s) GAAP net income Provision (benefit) for income taxes Net interest expense Foreign exchange / other expense Stock-based compensation expense Depreciation and amortization Transaction and integration costs Net loss on leases, restructuring, impairment & unoccupied lease charges Change in contingent consideration Adjusted EBITDA ($000s) Adjusted net income to GAAP net income GAAP net income Foreign exchange / other expense Stock-based compensation expense Amortization of purchased intangible assets Transaction and integration costs Net loss on leases, restructuring, impairment & unoccupied lease charges Change in contingent consideration Income tax expense (benefit) related to goodwill Non-GAAP Adjusted Net Income CareCloud $ 2,836 $ $ 2021 $ 157 440 241 5,396 12,195 1,364 2,005 (2,515) 22,119 $ 2021 2,836 $ 241 5,396 8,880 1,364 2,005 (2,515) 290 18,497 $ 2022 5,432 177 364 712 4,914 11,725 876 1,138 (3,090) 22,248 2022 5,432 712 4,914 6,277 876 1,138 (3,090) 75 16,334 Q4 2021 $ 3,522 177 176 73 1,390 2,689 Q4 2022 $ 246 340 (2,515) 6,098 $ Q4 2021 $ 3,522 $ 499 73 1,390 1,801 246 340 (2,515) 150 5,007 $ 33 83 353 1,515 3,039 152 210 (200) 5,684 Q4 2022 499 353 1,515 1,391 152 210 (200) 14 3,934 O CareCloud, Inc. 2023 18